Annemieke S. Littooij

Dr. Annemieke S. Littooij


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2014 in European Radiology
Verified
Journal Article
Closed access
PDF file
ALAnnemieke S. Littooij
Annemieke S. Littooij
TKThomas C. Kwee
Thomas C. Kwee
IBIgnasi Barber
Ignasi Barber
CGClaudio Granata
Claudio Granata
MVMalou A. Vermoolen
Malou A. Vermoolen
RNRutger A.J. Nievelstein
Rutger A.J. Nievelstein

8 May 2015 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
ALAnnemieke S. Littooij
Annemieke S. Littooij
TKThomas C. Kwee
Thomas C. Kwee
BKBart De Keizer
Bart De Keizer
MBMarrie C.A. Bruin
Marrie C.A. Bruin
ACAna Coma
Ana Coma
RNRutger A.J. Nievelstein
Rutger A.J. Nievelstein

3 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
JBJustine van der Beek
Justine van der Beek
JGJames I Geller
James I Geller
Ronald de KrijgerRonald de Krijger
Ronald de Krijger
NGNorbert Graf
Norbert Graf
KPKathy Pritchard-Jones
Kathy Pritchard-Jones
Marry van den Heuvel-EibrinkMarry van den Heuvel-Eibrink
Marry van den Heuvel-Eibrink
Pediatric renal cell carcinoma (RCC) is a rare type of kidney cancer, most commonly occurring in teenagers and young adolescents. Few relatively large series of pediatric RCC have been reported. Knowledge of clinical characteristics, outcome and treatment strategies are often based on the more frequently occurring adult types of RCC. However, published pediatric data suggest that clinical, molecular and histological characteristics of pediatric RCC differ from adult RCC. This paper summarizes reported series consisting of ≥10 RCC pediatric patients in order to create an up-to-date overview of the clinical and histopathological characteristics, treatment and outcome of pediatric RCC patients.

4 September 2017 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
ASAtia Samim
Atia Samim
ALAnnemieke S. Littooij
Annemieke S. Littooij
MHMarry M. van Den Heuvel-Eibrink
Marry M. van Den Heuvel-Eibrink
FWFrank J. Wessels
Frank J. Wessels
RNRutger A. J. Nievelstein
Rutger A. J. Nievelstein
PJPim A. de Jong
Pim A. de Jong
Background Normative data on pulmonary nodules in children without malignancy are limited. Knowledge of the frequency and characteristics of pulmonary nodules in healthy children can influence care decisions in children with malignant disease. Objective To provide normative data concerning the frequency and characteristics of pulmonary nodules on computed tomography (CT) in young children. Materials and methods All children ages 1 year–12 years who underwent chest CT after high-energy trauma were retrospectively investigated. Exclusion criteria were a history of malignancy, thick image slices, motion artefacts and extensive post-traumatic pulmonary changes. Two radiologists were asked to independently identify all nodules and to characterize each nodule with respect to location, size, perifissural location and calcification. Discrepancies were adjudicated by a third reader, who set the reference standard in this study. Interobserver agreement in detection and characterization was assessed using the kappa coefficient (κ). Results Identified were 120 patients, of whom 72 (75% male; median age: 8.0 years [interquartile range: 4–11]) were included. A total of 59 pulmonary nodules were present in 27 patients (38%; 95% confidence interval: 26–49%; range: 1–5 nodules per patient, with a mean diameter of 3.2 mm [standard deviation: 0.9 mm]). For nodule detection, the per-patient interobserver agreement was substantial (κ=0.78) and per-lobe agreement was moderate (κ=0.40). For characterization, there was fair to substantial agreement (κ=0.36–0.74). Conclusion Small pulmonary nodules on chest CT are a common finding in otherwise healthy children, but detection and characterization have only moderate interobserver agreement.

5 September 2022 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
ALAnnemieke S. Littooij
Annemieke S. Littooij
BKBart de Keizer
Bart de Keizer
Neuroblastoma is the most common extracranial solid malignancy of childhood. The prognosis is highly variable ranging from spontaneous involution in infants to fatal outcome, despite aggressive treatment, in disseminated high-risk neuroblastoma. This paper provides a comprehensive review of the crucial role of imaging during the extensive treatment course.

1 July 2017 in Pediatric Radiology
Verified
Journal Article
Open access
PDF file
ALAnnemieke S. Littooij
Annemieke S. Littooij
PNPeter G. Nikkels
Peter G. Nikkels
CKChristina A. Hulsbergen-Van de Kaa
Christina A. Hulsbergen-Van de Kaa
CVCees P. van de Ven
Cees P. van de Ven
MHMarry M. van Den Heuvel-Eibrink
Marry M. van Den Heuvel-Eibrink
ØOØystein E. Olsen
Øystein E. Olsen
Background Nephroblastomas represent a group of heterogeneous tumours with variable proportions of distinct histopathological components. Objective The purpose of this study was to investigate whether direct comparison of apparent diffusion coefficient (ADC) measurements with post-resection histopathology subtypes is feasible and whether ADC metrics are related to histopathological components. Materials and methods Twenty-three children were eligible for inclusion in this retrospective study. All children had MRI including diffusion-weighted imaging (DWI) after preoperative chemotherapy, just before tumour resection. A pathologist and radiologist identified corresponding slices at MRI and postoperative specimens using tumour morphology, the upper/lower calyx and hilar vessels as reference points. An experienced reader performed ADC measurements, excluding non-enhancing areas. A pathologist reviewed the corresponding postoperative slides according to the international standard guidelines. We tested potential associations with the Spearman rank test. Results Side-by-side comparison of MRI–DWI with corresponding histopathology slides was feasible in 15 transverse slices in 9 lesions in 8 patients. Most exclusions were related to extensive areas of necrosis/haemorrhage. In one lesion correlation was not possible because of the different orientation of sectioning of the specimen and MRI slices. The 25% ADC showed a strong relationship with percentage of blastema (Spearman rho=−0.71, P=0.003), whereas median ADC was strongly related to the percentage stroma (Spearman rho=0.74, P=0.002) at histopathology. Conclusion Side-by-side comparison of MRI–DWI and histopathology is feasible in the majority of patients who do not have massive necrosis and hemorrhage. Blastemal and stromal components have a strong linear relationship with ADC markers.